ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 98 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.21 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $414,126 | -39.3% | 130,639 | -4.8% | 0.02% | -37.8% |
| Q2 2023 | $682,043 | +10.8% | 137,232 | +10.1% | 0.04% | -2.6% |
| Q1 2023 | $615,578 | +426.1% | 124,611 | +1118.2% | 0.04% | +442.9% |
| Q2 2022 | $117,000 | +14.7% | 10,229 | -9.0% | 0.01% | +75.0% |
| Q1 2022 | $102,000 | -45.2% | 11,243 | -10.0% | 0.00% | -33.3% |
| Q4 2021 | $186,000 | -48.2% | 12,492 | -10.6% | 0.01% | -50.0% |
| Q3 2021 | $359,000 | +3.2% | 13,980 | +4.7% | 0.01% | 0.0% |
| Q2 2021 | $348,000 | -25.8% | 13,349 | +0.4% | 0.01% | -33.3% |
| Q1 2021 | $469,000 | +27.4% | 13,294 | -8.9% | 0.02% | +12.5% |
| Q4 2020 | $368,000 | -25.7% | 14,586 | +11.1% | 0.02% | -36.0% |
| Q3 2020 | $495,000 | -23.4% | 13,132 | -12.9% | 0.02% | -30.6% |
| Q2 2020 | $646,000 | +224.6% | 15,078 | +47.7% | 0.04% | +140.0% |
| Q1 2020 | $199,000 | -46.5% | 10,211 | -28.6% | 0.02% | -6.2% |
| Q4 2019 | $372,000 | +8.5% | 14,300 | +13.6% | 0.02% | -5.9% |
| Q3 2019 | $343,000 | – | 12,588 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |